Bertrand Mérot
Gründer bei Bio-Sourcing SA
Ursprung des Netzwerks ersten Grades von Bertrand Mérot
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
27
| Non-Profit Organization | Miscellaneous Commercial Services | 27 |
| Subsidiary | Biotechnology | 15 | |
Bio-Sourcing SA
 Bio-Sourcing SA BiotechnologyHealth Technology Bio-Sourcing SA develops and markets biological drugs for veterinary use. The firm focuses on farm animal health and companion animal health. The company was founded by Bertrand Mérot in June 2011 and is headquartered in Liege, Belgium.
6
| Holding Company | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bertrand Mérot
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director of Finance/CFO | |
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| MAINSTAY MEDICAL INTERNATIONAL | Medical Specialties | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| AIR LIQUIDE | Chemicals: Specialty | Corporate Officer/Principal | |
| UCB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NICOX SA | Pharmaceuticals: Major | Director of Finance/CFO | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
UCB Pharma SA (France)
 UCB Pharma SA (France) Pharmaceuticals: MajorHealth Technology Part of UCB SA, UCB Pharma SA (France) specializes in allergic and respiratory diseases and disorders. The company is based in Nanterre, France. | Pharmaceuticals: Major | Director/Board Member | |
ODDO BHF SE
 ODDO BHF SE Major BanksFinance ODDO BHF SE provides banking and financial services. It specializes in private banking, asset management, as well as corporate and investment banking. The company was founded in 1854 and is headquartered in Frankfurt, Germany. | Major Banks | Chief Executive Officer | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chairman | |
| THERADIAG | Medical Specialties | Chairman Chief Executive Officer | |
| OLMIX | Chemicals: Agricultural | Founder | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree | |
| École Normale Supérieure | College/University | Doctorate Degree Graduate Degree | |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Biotechnology | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
The Bridgespan Group
 The Bridgespan Group Miscellaneous Commercial ServicesCommercial Services The Bridgespan Group provides management strategies and tools. Its services include consulting to nonprofits and philanthropists, leadership development support, and developing and sharing insights. The company was founded by Thomas J. Tierney and Jeffrey L. Bradach and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MAbgène SA
 MAbgène SA BiotechnologyHealth Technology MAbgène SA is a French company that produces monoclonal antibodies and recombinant proteins through cell culture. The company is based in Alès, France. The company has two CLD platforms available, including a CHO-S platform and their proprietary EMABling® platform. LFB Biotechnologies SASU is a subsidiary of LFB BIOMANUFACTURING, which is ultimately controlled by the Government of France. MAbgène was acquired by LFB Biotechnologies SASU on November 30, 2007 for $4.09 million. | Biotechnology | President | |
| Bryan, Garnier & Co Ltd. (France) | Investment Banks/Brokers | Director of Research - Equity | |
| Université Catholique de Louvain | College/University | Graduate Degree Graduate Degree | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Biotechnology | Chairman Chief Executive Officer | |
Pierre Fabre Médicament Production SAS
 Pierre Fabre Médicament Production SAS Medical SpecialtiesHealth Technology Pierre Fabre Médicament Production SAS engages in the production of pharmaceutical products. It develops in the areas of oncology, ethics, and consumer health care. The company was founded in 1960 and is headquartered in Boulogne Billancourt, France. | Medical Specialties | Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member | |
Flash Therapeutics SAS
 Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
Natixis SA (Broker)
 Natixis SA (Broker) Investment Banks/BrokersFinance Natixis SA (Broker) is the securities brokerage division of Natixis SA (EPA: KN), a corporate and investment bank headquartered in Paris, France. They are ultimately owned by BCPE SA. The firm provides full spectrum of broking services to various investors. | Investment Banks/Brokers | Analyst-Equity | |
| Sorbonne Université | College/University | Graduate Degree | |
| Institut Supérieur de Gestion | College/University | Undergraduate Degree | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Amadéite SAS
 Amadéite SAS Food: Specialty/CandyConsumer Non-Durables Amadéite SAS manufactures and wholesales additives and food flavorings. It offers services to the food sectors. The company was founded on June 12, 1995 and is headquartered in Brehan, France. | Food: Specialty/Candy | Chief Executive Officer | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Founder | |
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
Pylote SA
 Pylote SA BiotechnologyHealth Technology Pylote SA conceives and develops mineral microspheres to sell solutions. Its products include mineral microspheres, material integration and pylote added. The company was founded by Loïc Marchin and is headquartered in Dremil-Lafage, France. | Biotechnology | Director/Board Member | |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member | |
| CORETECH 5 | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member | |
Amadéite
 Amadéite Financial ConglomeratesFinance Amadéite is an investment holding private company based in Brehan, France. Amadéite functions as an investment holding French company. The CEO of the company is Hervé Balusson. | Financial Conglomerates | Chief Executive Officer | |
Mainstay Medical Holdings Plc
 Mainstay Medical Holdings Plc Financial ConglomeratesFinance Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland. | Financial Conglomerates | Director/Board Member | |
Olgram SAS
 Olgram SAS Miscellaneous Commercial ServicesCommercial Services Olgram SAS provides scientific research and development services. The company is based in Brehan, France. The French company was founded by Hervé Balusson, Maryvonne Hiance, Karim Asehnoune, Pi Nyvall Collén, Pierre Rocheteau. Pierre Rocheteau has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
| Healthtech For Care | Corporate Officer/Principal | ||
| Life Sciences Acceleration Alliance eV | Director/Board Member | ||
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Director/Board Member |
Statistik
International
| Frankreich | 39 |
| Vereinigte Staaten | 7 |
| Belgien | 3 |
| Deutschland | 3 |
| Schweden | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 8 |
| Finance | 8 |
| Process Industries | 6 |
| Commercial Services | 6 |
Operativ
| Director/Board Member | 186 |
| Corporate Officer/Principal | 60 |
| Chairman | 48 |
| Chief Executive Officer | 40 |
| Independent Dir/Board Member | 29 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Franck Lescure | 28 |
| Mary Gray | 27 |
| Geoffrey F. Cox | 20 |
| William Heiden | 19 |
| Marc Le Bozec | 16 |
| Michel Finance | 15 |
| Cédric Moreau | 14 |
| Michel Helbig de Balzac | 14 |
| John Green | 13 |
| Loïc Maurel | 12 |
| Gilles Avenard | 11 |
| Yann Echelard | 11 |
| Renaud Vaillant | 10 |
| Christian Policard | 10 |
| Evelyne Nguyen | 10 |
- Börse
- Insiders
- Bertrand Mérot
- Unternehmensverbindungen